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Abstract 32 
This study investigates the relationship between autonomic function and the inflammatory 33 
response to a wheelchair half-marathon in people with a spinal cord injury (SCI). Seventeen 34 
wheelchair athletes with a cervical SCI (CSCI, N=7) and without CSCI (NON-CSCI, N=10) 35 
participated in a wheelchair half-marathon. Blood was taken prior, post and 1 h post-race to 36 
determine the concentrations of adrenaline, noradrenaline, extracellular heat shock protein 72 37 
(eHsp72) and interleukin-6 (IL-6). A sit-up tilt test was performed to assess autonomic 38 
function at rest. CSCI showed a lower supine ratio of the low and high frequency power of 39 
the variability in RR intervals (LF/HF RRI, p=0.038), total and low frequency power of the 40 
systolic blood pressure variability (TP SBP, p<0.001; LF SBP, p=0.005) compared to NON-41 
CSCI. Following the race, catecholamine concentrations increased only in NON-CSCI 42 
(p<0.036). The increase in IL-6 post-race was larger in NON-CSCI (p=0.040). Post-race 43 
catecholamine levels explained 60% of the variance in the IL-6 response (r=0.77, p=0.040), 44 
which was further increased when the resting autonomic function indices were added to the 45 
regression model (R2>81%, p<0.012). In summary, the dampened acute inflammatory 46 
response to a wheelchair half-marathon in CSCI was strongly associated with the autonomic 47 
dysfunction present in this group.  48 
 49 
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Introduction 54 
 Chronic low-grade inflammation, characterised by elevated resting levels of pro-55 
inflammatory proteins (e.g. interleukin-6 (IL-6) and extracellular heat shock protein 72 56 
(eHsp72)) and strongly associated with chronic diseases such as type 2 diabetes mellitus and 57 
cardiovascular disease, is more prevalent in people with a spinal cord injury (SCI) compared 58 
to members of the able-bodied population (Bauman & Spungen, 2008). This might be the 59 
consequence of a physically inactive lifestyle and the physiological changes accompanying 60 
the injury (Martin Ginis et al., 2010). Exercise training is widely recognised as a means to 61 
combat chronic low-grade inflammation (Petersen & Pedersen, 2005), partly as a result of the 62 
acute inflammatory response induced by each bout. Although transiently elevating pro-63 
inflammatory proteins such as IL-6, the subsequent longer lasting anti-inflammatory response 64 
can lower resting levels of these proteins when engaging in exercise on a regular basis 65 
(Petersen & Pedersen, 2005). During and shortly after exercise, the primary source of 66 
circulating IL-6 concentrations is skeletal muscle (Steensberg et al., 2000). Despite a smaller 67 
active muscle mass involved, upper-body exercise has been shown effective in the induction 68 
of an acute inflammatory response (Sasaki et al., 2014; Umemoto et al., 2011). However, this 69 
response might be attenuated in people with a cervical SCI (CSCI) (Paulson et al., 2013).  70 
Persons with CSCI have a smaller muscle mass and impaired autonomic function 71 
compared to able-bodied individuals and people with paraplegia, both impacting on their 72 
exercise capacity (West et al., 2015). There is limited research into the influence of these 73 
factors on the acute inflammatory response to exercise. Paulson et al. (2013) reported an 74 
attenuated IL-6 response to a strenuous bout of exercise in CSCI compared to SCI; a finding 75 
that was replicated in a wheelchair racing setting (Ogawa et al., 2014). Together with the 76 
attenuated IL-6 response, both studies reported a blunted adrenaline and noradrenaline 77 
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response to the exercise bout in the CSCI group (Ogawa et al., 2014; Paulson et al., 2013), 78 
suggesting a major role of catecholamines in the dampened acute inflammatory response to 79 
exercise present in people with CSCI. Indeed, adrenaline infusion in resting able-bodied 80 
individuals results in increased plasma IL-6 concentrations (Sondergaard et al., 2000; 81 
Steensberg et al., 2001), potentially via the increase of intracellular cyclic adenosine 82 
monophosphate (cAMP) following the stimulation of β-receptors on skeletal muscle with 83 
adrenaline (Sondergaard et al., 2000).   84 
Apart from resulting in lower resting and exercise-induced plasma catecholamine 85 
concentrations, CSCI can lead to the disruption of sympathetic innervation of the heart, as 86 
well as the skin and blood vessels below the lesion (Krassioukov, 2009). Consequently, 87 
members of this population have an impaired blood pressure regulation and heart rate (HR) 88 
attained during maximal exercise does often not exceed ~130 bpm (West et al., 2015). 89 
Therefore, although an attenuated catecholamine response to exercise is a characteristic of 90 
autonomic dysfunction, the latter affects a plethora of other physiological processes that may 91 
influence the acute inflammatory response to exercise. As autonomic completeness of a 92 
spinal injury varies between people as a result of the potential sparing of autonomic fibres 93 
below the lesion (Krassioukov, 2009), the impact of autonomic dysfunction on the 94 
inflammatory response to exercise may also differ between people with SCI.  95 
For a more comprehensive assessment of autonomic function than using exercise-96 
induced plasma catecholamine concentrations alone (Paulson et al., 2013; Ogawa et al., 2014), 97 
additional tests exist (Krassioukov, 2009). The sit-up tilt test, for instance, can be used to 98 
detect abnormal changes in HR and blood pressure in response to a passive tilt manoeuvre 99 
(Claydon & Krassioukov, 2008). Moreover, Claydon & Krassioukov (2008) reported that 100 
frequency blood pressure and heart rate variability measures taken in a supine position are 101 
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predictive of a range of clinical measures of autonomic dysfunction, such as for instance 102 
orthostatic hypotension.  103 
 The present study therefore extends on previous research (Ogawa et al., 2014; 104 
Paulson et al., 2013) by incorporating autonomic function indices measured at rest in addition 105 
to the assessment of the catecholamine response following exercise to investigate the 106 
association of autonomic function with the inflammatory response to a wheelchair half-107 
marathon. In addition, this study investigates the potential of upper-body exercise in SCI to 108 
acutely elevate eHsp72 concentrations, a relatively novel marker implicated in chronic low-109 
grade inflammation (Johnson & Fleshner, 2006). Together, this can provide further insight 110 
into factors that influence the acute inflammatory response to exercise and inform strategies 111 
to reduce chronic low-grade inflammation in people with CSCI. 112 
 113 
Methods 114 
Participants were seventeen male recreational wheelchair athletes with CSCI (N=7) or 115 
without CSCI (NON-CSCI, N=10), the latter group including individuals with a spinal lesion 116 
below the cervical level (N=6), spina bifida (N=2), polio (N=1) and myotonia congenita (N=1) 117 
(Table 1). Participants took part in the wheelchair half-marathon of Oita 2016. The study was 118 
approved by the local ethics committees of Loughborough University (United Kingdom) and 119 
Wakayama University (Japan) and participants gave informed consent prior to participation.   120 
 121 
Sit-up tilt test 122 
 123 
One to 2 days prior to the race, a sit-up tilt test was conducted in 16 of the 17 athletes 124 
for the assessment of autonomic function. All tests were performed using the same 125 
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wheelchair with adjustable back rest and in a room set at 25°C. Participants were rested for 5 126 
minutes in a supine position and were then elevated into the sitting position, which they 127 
maintained for another 5 minutes. Participants were instructed to breathe at a frequency of 128 
0.25 Hz. Blood pressure was measured beat-by-beat at the wrist (MUB101-50, MediSense 129 
Inc., Tokyo, Japan) whilst a brachial blood pressure cuff (STBP-780, Colin, Komaki, Japan) 130 
was used for the calibration. Both cuffs were situated at the level of the heart for the full 131 
duration of the test. Heart rate was continuously monitored using a 7-lead electrocardiogram 132 
(PhysioFlow Lab-1, Manatec Biomedical, Paris, France). Following the test, participants 133 
reported their height, body mass, wheelchair racing experience and average time spent 134 
training.  135 
To obtain HR and blood pressure variability measures in the frequency domain, beat-136 
to-beat mean arterial pressure and HR were obtained by integrating the respective signals 137 
within each cardiac cycle. Cardiac cycles were determined based on the diastolic intervals of 138 
the beat-to-beat blood pressure signal. Beat-to-beat mean arterial pressure and HR were first 139 
linearly interpolated and resampled at 2Hz and then detrended by subtracting their third 140 
polynomial. Subsequently, the beat-to-beat time series were used for the spectral analyses 141 
based on the Welch algorithm. Each time series was subdivided into successive 256-point 142 
Hann windows that overlapped by 50% before fast Fourier transform analysis (Van der 143 
Scheer et al., 2018). Outcome measures used to reflect autonomic function were: the largest 144 
drop in blood pressure following the onset of the sitting position (to detect orthostatic 145 
hypotension (OH), defined as a drop in SBP>20 mmHg or DBP>10 mmHg (Freeman et al., 146 
2011)), the ratio of the power in the low (power = 0.07 – 0.20 Hz) and high frequency (power 147 
= 0.20 – 35 Hz) domain of the heart rate variability (LF/HF RRI), total power and power in 148 
the low frequency domain of systolic blood pressure variability (TP SBP and LF SBP, 149 
respectively) in the supine position (Claydon & Krassioukov, 2008). These variability 150 
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measures were chosen as they have been shown reliable in people with SCI (Ditor et al., 2005) 151 
and to strongly correlate with clinical symptoms of autonomic dysfunction (Claydon & 152 
Krassioukov, 2008). Additionally, the root mean square differences of successive R-R 153 
intervals in the supine position (RMSSD) was included as a time domain autonomic function 154 
index. 155 
 156 
Wheelchair half-marathon 157 
 158 
The Oita wheelchair half-marathon is a 21.1 km race on relatively flat terrain in the 159 
city centre. The race started at 10am in relatively mild conditions (23°C, 56% relative 160 
humidity). Participants had refrained from exercise in the 24 hours prior to the race. While 161 
food and liquid ingestion were not controlled due to the potential interference with the race 162 
practices of the athletes, these were reported using a food diary. All participants reported to 163 
have consumed a carbohydrate-rich breakfast in the morning of the race and to have 164 
consumed a sports drink during the race. Heart rate was continuously measured using a 165 
Garmin monitor (Garmin Edge 500, US). Blood was drawn from an antecubital vein prior to 166 
the warm-up for the race (pre), directly after finishing the race (post) and 1 h post-race (1 h 167 
post) into a glass serum separation and a K3EDTA tube of which respectively serum and 168 
plasma were extracted and stored at -80 °C until analysis. These time-points were chosen 169 
based on previous studies on the acute inflammatory response to endurance-type exercise in 170 
able-bodied (Fehrenbach et al., 2005; Fischer, 2006) and individuals with disability (Ogawa 171 
et al., 2014). Interleukin-6 (High sensitivity; R&D systems, UK) and eHsp72 (Amp`d high 172 
sensitivity; Enzo life sciences, US) were analysed in serum using a quantitative sandwich-173 
type enzyme-linked immunosorbent assay (CV: 8.2% and 6.3%, respectively), while 174 
adrenaline and noradrenaline were analysed in plasma by high-performance liquid 175 
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chromatography. Haemoglobin and haematocrit were determined using an automated cell 176 
counter (MEK-6400, Nihon Koden, Tokyo, Japan) and were used to correct the outcome 177 
markers for changes in plasma volume resulting from the race (Dill and Costil, 1964). 178 
 179 
Statistical analyses 180 
 181 
The participants were divided into two groups based on lesion level (regardless of 182 
completeness), resulting in a CSCI and NON-CSCI group. All data were checked for 183 
normality with the Shapiro-Wilk test, after which the data were log-transformed when this 184 
assumption was violated. Data were checked for sphericity using Levene`s test. Comparisons 185 
of athlete characteristics and responses to the sit-up tilt test between CSCI and NON-CSCI 186 
were assessed using independent student T-tests. Two-way repeated measures ANOVAs 187 
were used to assess changes in IL-6, eHsp72, adrenaline and noradrenaline in CSCI and 188 
NON-CSCI following the race. 95% confidence intervals of the difference in participants` 189 
characteristics between both groups were computed, while effect sizes (ES) Cohen`s d were 190 
calculated where appropriate, whereby an ES of 0.20, 0.5 and 0.80 refers to a small, moderate 191 
or large effect, respectively (Cohen, 1992). The ES for a time x group interaction was 192 
calculated by comparing the pre-post change scores in each group. Using GPower 3.1.9.2, we 193 
calculated we would need six participants in both groups to detect a difference in the acute 194 
IL-6 response to exercise between the groups, with 90% power, an α of 5% and an effect size 195 
of 2.0 based on data reported by Ogawa et al. (2014). 196 
To further assess the relationship of catecholamines and the autonomic function 197 
indices with the inflammatory response following the race, simple and multiple linear 198 
regression analysis using the whole sample was performed. Adrenaline and noradrenaline 199 
were entered into the model both together and individually and the R2 was used to describe 200 
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the explained variance of the dependent variable. The same was done for LF/HF RRI, 201 
RMSSD, LF SBP and TP SBP. Finally, adrenaline and noradrenaline together with a heart 202 
rate and blood pressure variability measure were entered into the regression model and the 203 
change in R2 as compared to the model with the catecholamines or sit-up tilt test indices only 204 
was tested using ANOVA. Collinearity among the predictor variables was tested using 205 
Tolerance and the Condition Index, whereby values higher than 1 and 15 respectively were 206 
considered concerning (Midi et al., 2010). All analyses were performed using the 23rd version 207 
of SPSS and statistical significance was defined as p<0.05.  208 
Results 209 
Sit-up tilt test 210 
 211 
            Five participants demonstrated OH in response to the tilt manoeuvre, four of which 212 
were in the CSCI group and one in NON-CSCI. Athletes in the CSCI group showed a larger 213 
drop in SBP in response to the tilt manoeuvre compared to NON-CSCI (p=0.017; ES: 1.36). 214 
LF/HF RRI (p=0.038; ES: 1.30), LF SBP (p=0.005; ES: 1.86) and TP SBP (p<0.001; ES: 215 
2.37) differed significantly between the two groups, with NON-CSCI showing larger values. 216 
The RMSSD did not differ between both groups (p = 0.87) (Table 1). As such, the remaining 217 
of this manuscript focusses on the frequency rather than time domain autonomic function 218 
indices at rest. 219 
*****Table 1 near here****** 220 
Wheelchair half-marathon 221 
 222 
At rest, CSCI had lower levels of adrenaline (p=0.003; ES: 1.62) and noradrenaline 223 
(p<0.001; ES: 3.20) compared to NON-CSCI. While there was no difference in baseline IL-6 224 
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serum concentrations (p=0.519), a strong trend for higher resting eHsp72 concentrations for 225 
CSCI compared to NON-CSCI was present (p=0.055; ES: 1.04) (Fig. 1).  226 
 227 
The NON-CSCI group took significantly less time to complete the race than the CSCI 228 
athletes (1.06 (0.21) versus 1.43 (0.38) h, p=0.026; ES: 1.21). The average HR during the 229 
race was significantly higher for NON-SCI compared to CSCI (145 (32) versus 103 (20) bpm, 230 
p=0.029; ES: 1.43). There was a trend for a higher peak HR in the NON-CSCI group (166 231 
(41) versus 129 (18) bpm, p=0.087; ES: 1.04).  232 
 233 
Following the race, plasma adrenaline and noradrenaline concentrations were 234 
increased in NON-CSCI (p<0.036; ES: 1.60 and 1.58 for adrenaline and noradrenaline, 235 
respectively), but not in CSCI (p>0.113; ES: 0.63 and 0.84 for adrenaline and noradrenaline, 236 
respectively). The increase in serum IL-6 concentrations in response to the race was larger in 237 
NON-CSCI compared to CSCI (p=0.040; ES: 0.71), although the latter group showed a 238 
significant increase in IL-6 as well (p=0.033; ES: 1.03). Extracellular heat shock protein 72 239 
did not increase in either of the groups (NON-CSCI: p=0.338 and CSCI: p=0.116) (Fig. 1). 240 
Since both IL-6 and eHsp72 concentrations did not change from post to 1 h post (p>0.391), 241 
further analyses were performed using the serum concentrations of both markers immediately 242 
following the race only.    243 
 244 
****** Figure 1 near here****** 245 
Association of autonomic function with the inflammatory response 246 
 247 
The relationship between the autonomic function indices, catecholamines and the 248 
inflammatory response to the race is illustrated in Table 2 and Figure 2. Post-race levels of 249 
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adrenaline and noradrenaline combined explained 60% of the variance in the IL-6 250 
concentrations following to the race (p=0.04), while adrenaline alone explained 44% of the 251 
variance (p=0.007). The LF/HF RRI and TP SBP both individually explained a significant 252 
proportion of the variance in post-race plasma adrenaline concentrations (29% and 33%, 253 
respectively; p<0.042). The model including combination of LF/HF RRI with LF SBP or TP 254 
SBP did not significantly explain the adrenaline response (p>0.08). The variance in the IL-6 255 
response could not be explained by one of the autonomic function indices in isolation (LF/HF 256 
RRI: R2 = 8%, p=0.37; RMSSD: R2 = 11%, p=0.28; LF SBP: R2 = 12%, p=0.27; TP SBP: R2 257 
= 29%, p=0.07). The same was true for the combination of LF/HF RRI together with either of 258 
the two variability measures of systolic blood pressure (p>0.281). The regression model 259 
including adrenaline, noradrenaline, LF/HF RRI and one of the systolic blood pressure 260 
variability measures (i.e. LF SBP or TP SBP) increased the explained variance of post-race 261 
IL-6 concentrations in comparison to the model including catecholamines only (R2>81%, 262 
p<0.012). The change in R2 compared with the model including catecholamines only was 263 
significant (adrenaline, noradrenaline, LF/HF RRI, TP SBP; p=0.036), or showed a trend 264 
towards significance (adrenaline, noradrenaline, LF/HF RRI, LF SBP; p=0.07). Of note, 265 
Tolerance and the Condition Index were <0.54 and <8.87, respectively, indicating no 266 
substantial collinearity among the predictor variables. Finally, athletes that presented with 267 
OH during the sit-up tilt test showed lower levels of adrenaline (104 (131) mmol/L versus 268 
265 (243) mmol/L) and IL-6 (4.34 (1.08) pg/ml versus 10.21 (6.84) pg/ml) post-race, 269 
although only the difference in IL-6 reached statistical significance (p=0.192; ES: 0.66 and 270 
p=0.026; ES: 0.96, respectively).  271 
 272 
********Table 2 and Figure 2 near here********* 273 
 274 
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Discussion 275 
This study showed that the acute IL-6 response to a wheelchair half-marathon is 276 
attenuated in CSCI compared to NON-CSCI athletes, predominantly associated with the 277 
blunted catecholamine response observed in this group. Although autonomic function indices 278 
assessed at rest do not seem to be strong independent predictors for the IL-6 response to 279 
exercise, when used in combination with catecholamines they enhanced the predictive value 280 
of autonomic function assessments. This suggests that the influence of autonomic dysfunction 281 
on the dampened IL-6 response in people with CSCI is mediated by more than 282 
catecholamines only. Finally, eHsp72 was not elevated after the wheelchair half-marathon, 283 
suggesting that more intense or longer duration upper-body exercise is needed to increase its 284 
release into the circulation. 285 
The resting autonomic function indices in the frequency domain (i.e. LF/HF RRI, LF 286 
SBP and TP SBP) differed between CSCI and NON-CSCI, indicating a difference in 287 
autonomic function between the two groups. Importantly, Claydon and Krassioukov (2008) 288 
observed a strong correlation between those measures and clinical outcomes of autonomic 289 
dysfunction (e.g. the catecholamine, HR and blood pressure response to the tilt manoeuvre as 290 
well as the sympathetic skin responses). As suggested by these authors, this may provide 291 
practitioners with an easy-to-use and non-invasive tool to assess autonomic function in 292 
people with SCI (Claydon & Krassioukov, 2008). Further indicating a difference in 293 
autonomic function between NON-CSCI and CSCI, the latter showed lower plasma 294 
concentrations of adrenaline and noradrenaline at rest and in response to exercise.  295 
Previous research using only catecholamines as an indication of autonomic function 296 
has highlighted the importance of an intact sympathetic nervous system for the elevation of 297 
IL-6 following exercise (Ogawa et al., 2014; Paulson et al., 2013). Indeed, in the current 298 
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study catecholamines explained 60% of the variance in serum IL-6 levels post-race. Studies 299 
infusing adrenaline in persons at rest support the notion that adrenaline can independently 300 
elevate circulating IL-6 concentrations (Sondergaard et al. 2000; Steensberg et al. 2001). 301 
Animal studies using adrenergic receptor antagonists suggest that adrenaline stimulates IL-6 302 
production by the activation of β-receptors (De Rijk et al. 1994), which in turn leads to an 303 
increase in intracellular cAMP (Langfort et al., 2003). This can directly stimulate IL-6 304 
production (Zhang et al., 1988). Additionally, the impact of adrenaline on muscle glycogen 305 
breakdown may mediate its stimulating effect on IL-6 production (Jensen et al., 1999). 306 
Indeed, exercise in a glycogen depleted state leads to an exacerbated acute IL-6 response 307 
(Bishop et al., 2001). However, the infusion of similar adrenaline levels as observed during 308 
exercise results in a much lower elevation in IL-6 when compared to exercise (Steensberg et 309 
al., 2001), suggesting that exercise provides additional stressors that cause the elevation of 310 
circulating IL-6 concentrations.  311 
As circulating catecholamines seem to only partly explain the acute IL-6 response to 312 
exercise (Steensberg et al., 2001), other consequences of autonomic dysfunction such as the 313 
altered vascular tone and sympathetic innervation of the heart might further impact on the 314 
capacity to induce an inflammatory response through exercise (Paulson et al., 2013). 315 
Autonomic function indices taken at rest are associated with clinical symptoms of autonomic 316 
dysfunction (Claydon & Krassioukov, 2008), but also exercise performance (West et al., 317 
2015). In the present study, the predictive value of the individual autonomic function indices 318 
measured at rest seems to be limited with regards to the inflammatory response. However, the 319 
addition of these measures to the regression model with catecholamines significantly 320 
enhanced the explained variance of post-race serum IL-6 concentrations. This suggests that a 321 
combination of exercise-induced (catecholamines) and resting autonomic function indices 322 
(supine LF/HF RRI, LF SBP and TP SBP) can provide additional insight into the role of 323 
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sympathetic dysfunction in the acute IL-6 response to exercise in people with SCI. This may 324 
be used to inform individual exercise prescription as well as the creation of additional 325 
strategies to promote health in people with SCI (Leicht et al., 2015). From a mechanistic 326 
perspective, the added predictive value of autonomic function indices at rest suggests that the 327 
impact of autonomic dysfunction on the dampened acute inflammatory response to exercise is 328 
indeed mediated by other factors than blunted circulating catecholamine concentrations only.  329 
The close link between autonomic function and the catecholamine response to 330 
exercise makes it difficult to suggest what is accounted for by the resting autonomic function 331 
indices that is not accounted for by post-race catecholamine concentrations. In this respect it 332 
is noteworthy that athletes with autonomic complete CSCI might still experience autonomic 333 
reflexes below the lesion, resulting in spill-over of noradrenaline into the circulation (Leicht 334 
et al., 2013). Interestingly, one participant with CSCI showed a 4-fold and 2.5-fold increase 335 
in adrenaline and noradrenaline post-race respectively, despite being classified with a 336 
complete lesion and showing OH during the sit-up tilt test. Moreover, this was accompanied 337 
by an almost 4-fold increase in IL-6 following the race. Therefore, the impact of sympathetic 338 
reflexes and additional consequences of autonomic dysfunction other than lowered 339 
catecholamine concentrations on the acute inflammatory response to exercise would be an 340 
intriguing subject for future research.  341 
While there is now sufficient evidence for the ability of upper-body exercise to induce 342 
an IL-6 response (e.g. Kouda et al., 2012; Paulson et al., 2013), this is not yet the case for 343 
eHsp72. In the current study no elevation of eHsp72 concentrations was detected in either 344 
CSCI or NON-CSCI. In a study investigating able-bodied participants, Leicht et al. (2016) 345 
reported an increase in eHsp72 after 45 min of arm-cranking at 60-65% peak power output in 346 
a non-permeable suit as opposed to the absence of an eHsp72 response after the same bout of 347 
exercise in conventional sport clothes. Since the exercise bout in the non-permeable suit 348 
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resulted in increased heat storage, the results of this study suggest an important role of body 349 
temperature in the eHsp72 response. Since studies on lower-body exercise have shown 350 
increases in eHsp72 levels following relatively moderate bouts of exercise (Walsh et al., 351 
2001), the reason for the attenuated eHsp72 response following upper-body exercise might 352 
partly lie in the limited muscle mass involved, inducing smaller increases in core temperature 353 
during exercise (Price, 2006). On the other hand, thermoregulation during exercise is 354 
impaired in individuals with SCI, possibly resulting in higher attained core temperatures 355 
(Price & Campbell, 2003). Future research in applied settings should therefore attempt to 356 
monitor core temperature during competition to shed more light on this measure as a potential 357 
mediator of the inflammatory response (Laing et al., 2008; Whitham et al., 2007).  358 
Some limitations of this study need consideration. First, we were not able to monitor 359 
sleep, warm-up practices, psychological stress prior and during the race, nor control food and 360 
liquid intake on the day of the race. These factors may have impacted on the acute 361 
inflammatory response following the race. Furthermore, the physiological underpinning of 362 
heart rate and blood pressure variability measures in the frequency domain have been the 363 
subject of debate (Billman, 2013). While it is indeed questionable whether LF HRV and LF 364 
SBP reflect solely sympathetic activation (Billman, 2013), the measures included in the 365 
present study strongly correlate with more clinical outcomes of autonomic dysfunction 366 
(Claydon & Krassioukov, 2008). Moreover, these measures have been shown reliable in 367 
people with SCI (Ditor et al., 2005). Nevertheless, they should be considered as autonomic 368 
function indices, rather than measures of sympathetic activation (Esco et al., 2018). 369 
Additionally, the present study has assessed the relationship between autonomic function 370 
indices and the acute inflammatory response to strenuous exercise such as a wheelchair half-371 
marathon. Therefore, caution needs to be applied when translating the findings to shorter, 372 
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moderate-intensity exercise prescribed to promote health in the general population with SCI 373 
(Martin Ginis et al., 2018).  374 
Notwithstanding its limitations, appreciating the scarcity of available data on the 375 
effects of exercise and autonomic dysfunction on health in people with SCI (Buker et al., 376 
2018), the present field study in recreational wheelchair athletes may be used to inform future 377 
research in this area. For instance, the positive effect of chronic exercise training on 378 
autonomic balance (Buker et al., 2018) provides rationale for research into its impact on the 379 
acute inflammatory response to exercise, while further study is also needed to determine the 380 
most appropriate measures to indicate autonomic function in people with SCI (El-Kotob et al., 381 
2017). Furthermore, there is increasing evidence for the anti-inflammatory effect of 382 
resistance training (Strasser et al., 2012). To further inform exercise prescription, future 383 
research could investigate the effectiveness of different types of (standardised) exercise in 384 
inducing an acute inflammatory response to people with SCI.   385 
           In summary, the strong association between post-race serum IL-6 and catecholamine 386 
concentrations suggests a major role for the latter in the acute inflammatory response to a 387 
wheelchair half-marathon. While autonomic function indices assessed at rest were not 388 
predictive of the IL-6 response to the race when used in isolation, they enhanced the 389 
predictive value of autonomic function assessments when added to a predictive model with 390 
catecholamines alone. Therefore, the dampened acute IL-6 response to a wheelchair half-391 
marathon observed in people with CSCI may be influenced by more factors associated with 392 
autonomic dysfunction than solely blunted circulating catecholamine concentrations. Taking 393 
a wide range of factors associated with autonomic dysfunction into account may hence be of 394 
use to inform health promoting strategies to reduce chronic low-grade inflammation in 395 
individuals with CSCI. 396 
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Table 1. Characteristics of the participants with (CSCI) compared to the participants without (NON-CSCI) a 423 
cervical spinal cord injury. Values are given in mean (SD). 424 
 425 
Table 2. Regression analyses with autonomic function indices and the inflammatory response to the wheelchair 426 
half-marathon. Reported as R2 (r) 427 
Fig. 1 Changes in circulating concentrations of IL-6, eHsp72, adrenaline and noradrenaline in response to the 428 
wheelchair half-marathon. Connected dots represent the individual responses, whilst horizontal lines represent 429 
the mean difference of the group between pre-and post-race, including the positive standard deviation of the 430 
difference. * Significant difference between pre- and post-race. ^ Significant time x group interaction between 431 
NON-CSCI and CSCI (p<0.05). Graphs created using the template provided by Weissgerber et al. (Weissgerber, 432 
Milic, Winham, & Garovic, 2015). 433 
 434 
Fig. 2 Individual relationships between post-race concentrations of adrenaline, noradrenaline and eHsp72 with 435 
post-race IL-6 concentrations for CSCI (O) and NON-CSCI (+). * Variable significantly explains variance in 436 
post-race IL-6 concentrations (p<0.05).  437 
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Table 1. Characteristics of the participants with (CSCI) compared to the participants without (NON-CSCI) a 
cervical spinal cord injury. Values are given in mean (SD). 
 
 
Parameter NON-CSCI (N=10) CSCI (N=7) NON-SCI vs. CSCI 
mean (95%CI) 
difference 
Age (yrs) 43.5 (12.1) 43.4 (15.0) -0.7(-14.1 to 13.9) 
Height (cm) 155.3 (23.3) 172.6 (7.8) 17.3(-2.4 to 37.0) 
Body mass (kg) 53.8 (11.4) 60.0 (15.8) 6.2(-8.4 to 20.8) 
Wheelchair racing experience (yrs) 15.1 (9.6) 16.3 (10.2) 1.2(-11.0 to 13.4) 
Training per week (min) 313 (245) 307 (193) -5(-273 to 262) 
Lesion level SCI <Thoracic 5 >Cervical 8 NA 
Sensory and motor complete/incomplete 
SCI 
N=4/1 N=3/4 -1/3 
Orthostatic hypotension  N=1 
 
N=4 
 
3 
Change in SBP/DBP following tilt (mmHg) 
 
-2 (12) / -4 (7) -21 (10)/-5 (11) -18.1(-32.3 to -3.7)
*
/ 
-0.9(-11.0 to 9.2) 
Supine LF/HF RRI  1.65 (1.22) 0.34 (0.20) -1.31(-2.53 to -0.36) 
*
 
Supine LF SBP (Hz) 7.54 (3.71) 1.39 (1.95) -6.15(-10.07 to -2.22)
* 
Supine TP SBP (Hz) 5.96(3.74) 36.34(11.27) -30.3(-41.9 to -18.9)* 
Supine RMSSD (ms) 42.6(11.1) 46.6(23.1) 3.95(-46.0 to 53.9) 
Abbreviations: SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate; LF/HF RRI = 
ratio of the power in the low and high frequency domain of the heart rate variability; LF SBP = power in the low 
frequency domain of systolic blood pressure variability; TP SBP = total power of systolic blood pressure 
variability. Orthostatic hypotension is defined as a drop in SBP>20 mmHg or DBP>10 mmHg following the 
onset of the sitting position. * Significant difference between NON-CSCI and CSCI (p<0.05). 
 
Table 
Table 2. Regression analyses with autonomic function indices and the inflammatory response to the wheelchair 
half-marathon. Reported as R2 (r) 
Predictor variable IL-6 post-race Adrenaline post-race Noradrenaline post-race 
A 44% (0.66)* N/A 67% (0.82)* 
N 8% (0.29) 67% (0.82)* N/A 
LF/HF RRI 8% (0.28) 29% (0.54)* 11% (0.33) 
LF SBP 12% (0.35) 19% (0.44) 34% (0.58)*  
TP SBP 29% (0.54) 33% (0.58)* 28% (0.53) 
RMSSD 11% (0.33) 5% (0.23) 3% (0.18) 
A + N 60% (0.77)* N/A N/A 
LF/HF RRI + LF SBP 14% (0.36) 33% (0.58) 34% (0.59) 
LF/HF RRI + TP SBP 27% (0.52) 38% (0.61) 25% (0.50) 
RMSSD + LF SBP 6% (0.24) 21% (0.46) 34% (0.58) 
RMSSD + TP SBP 34% (0.58) 36% (0.60) 30% (0.55) 
A + N + LF/HF RRI + LF SBP 81% (0.90)*  N/A N/A 
A + N + LF/HF RRI + TP SBP 88% (0.94)* N/A N/A 
A + N + RMSSD + LF SBP 64% (0.80) N/A N/A 
A + N + RMSSD + TP SBP 72% (0.85)* N/A N/A 
Abbreviations: IL-6 = interleukin-6; A = adrenaline post-race; N = noradrenaline post-race; LF/HF RRI = ratio 
of the power in low and high frequency of the heart rate variability; LF SBP = power in the low frequency of 
systolic blood pressure variability; TP SBP = total power of systolic blood pressure variability; RMSSD = root 
mean square differences of successive R-R intervals. 
* Regression model significantly explains variance in dependent variable (p<0.05) 
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Fig. 1 Changes in serum concentrations of IL-6, eHsp72, adrenaline and noradrenaline in response to the 
wheelchair half-marathon. Connected dots represent the individual responses, whilst horizontal lines represent 
the mean difference of the group between pre-and post-race, including the positive standard deviation of the 
difference. * Significant difference between pre- and post-race. ^ Significant time x group interaction between 
NON-CSCI and CSCI (p<0.05). Graphs created using the template provided by Weissgerber et al. (Weissgerber, 
Milic, Winham, & Garovic, 2015). 
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Fig. 2 Individual relationships between post-race serum concentrations of adrenaline, noradrenaline and eHsp72 
with post-race IL-6 serum concentrations for CSCI (O) and NON-CSCI (+). * Variable significantly explains 
variance in post-race IL-6 serum levels (p<0.05).  
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